EUVIMEDEUVIMED entdecken
Crossref

L26/P-382 Artificial intelligence governance in assisted reproductive technology: comparative regulatory frameworks across EU and UK jurisdictions

V. Robertson, C. Doherty

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.716 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von V. Robertson und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question How do EU Member States and the UK regulate AI/ML deployment in embryo selection and ART clinical decision-making? Summary answer Regulatory approaches vary significantly; most jurisdictions lack AI-specific ART oversight, creating compliance uncertainty and cross-border treatment inconsistencies. What is known already AI/ML algorithms increasingly assist embryologists in embryo grading, predicting implantation success, and optimising treatment protocols. The EU AI Act (2024) classifies certain medical AI as high-risk, whilst the UK pursues sector-specific regulation through the HFEA. However, fragmented national interpretations of AI governance standards persist. Existing literature identifies gaps in transparency requirements, algorithmic accountability, and clinical validation thresholds. Legal uncertainty surrounds liability allocation when AI contributes to treatment outcomes, and patients’ rights to explanation remain contested across jurisdictions. Study design, size, duration Comparative legal analysis of regulatory frameworks in ten jurisdictions (UK, Germany, France, Spain, Italy, Netherlands, Belgium, Denmark, Sweden, Ireland) examining primary legislation, regulatory guidance, HFEA policy positions, and EU AI Act implementation measures Participants/materials, setting, methods Doctrinal analysis of legislation, regulatory authority guidance documents, enforcement decisions, and policy consultations applying comparative law methodology to identify convergence, divergence, and regulatory gaps across selected jurisdictions. Main results and the role of chance Analysis reveals fragmented regulatory approaches. Most jurisdictions retain embryo selection AI within existing medical device frameworks without ART-specific modifications, whilst others propose bespoke AI oversight mechanisms requiring pre-deployment regulatory approvals. The EU AI Act’s high-risk classification applies inconsistently across Member States; conformity assessment requirements vary substantially. Transparency obligations demonstrate considerable divergence, ranging from minimal disclosure requirements to mandatory algorithmic explanation provisions. Liability frameworks predominantly apply traditional medical negligence principles; limited jurisdictions explicitly address AI-mediated harm. Patient consent standards for AI-assisted treatment show substantial variation across the examined regulatory regimes. Limitations, reasons for caution Rapid regulatory evolution may render findings obsolete. Analysis limited to accessible legislative and regulatory materials. Enforcement data remains sparse given recent implementation timelines. Wider implications of the findings Findings inform cross-border treatment planning, compliance strategies, and harmonisation initiatives. Regulatory divergence may incentivise forum-shopping and undermine patient protection standards. Trial registration number No

Zitieren

APA

Robertson, V., & Doherty, C. (2026). L26/P-382 Artificial intelligence governance in assisted reproductive technology: comparative regulatory frameworks across EU and UK jurisdictions. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.716

Vancouver

Robertson V, Doherty C. L26/P-382 Artificial intelligence governance in assisted reproductive technology: comparative regulatory frameworks across EU and UK jurisdictions. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.716

BibTeX
@article{Robertson2026,
  author = {Robertson, V. and Doherty, C.},
  title = {L26/P-382 Artificial intelligence governance in assisted reproductive technology: comparative regulatory frameworks across EU and UK jurisdictions},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.716}
}
Kostenlos starten →